---
title: FUJIFILM Biotechnologies vs Samsung Biologics
slug_a: fujifilm-biotechnologies
slug_b: samsungbiologics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/fujifilm-biotechnologies/samsungbiologics
---

# FUJIFILM Biotechnologies vs Samsung Biologics

Side-by-side profile data from each company listing on this directory.

## FUJIFILM Biotechnologies

- Profile: [/companies/fujifilm-biotechnologies](/companies/fujifilm-biotechnologies)

FUJIFILM Biotechnologies — CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities.

Services: 18. Modalities: 5. Indications: 0. Locations: 13. Certifications: 0. The strongest documented coverage currently appears in services (18).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Viral Vector Manufacturing
- Cell Therapy Manufacturing
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector
- Expression: Cell-Free
- Single-Use / Disposable
- Stainless Steel

## Samsung Biologics

- Profile: [/companies/samsungbiologics](/companies/samsungbiologics)

Samsung Biologics — Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.

Services: 23. Modalities: 5. Indications: 1. Locations: 8. Certifications: 0. The strongest documented coverage currently appears in services (23).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- mRNA
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Prefilled Syringes (PFS)
- Cartridges
- Max bioreactor: Large commercial (≤10,000 L)
- Expression: Mammalian
- Expression: Cell-Free
- Single-Use / Disposable
- Stainless Steel